Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union
This rating reflects Lupin's leadership in environmental transparency and performance
Subscribe To Our Newsletter & Stay Updated
